Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
6.59
-0.41 (-5.86%)
Apr 27, 2026, 4:00 PM EDT - Market closed
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of $7.22 million as of April 27, 2026. Its market cap has increased by 15.14% in one year.
Market Cap
7.22M
Enterprise Value
4.48M
1-Year Change
15.14%
Ranking
Category
Stock Price
$6.59
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from $323.99M to $7.22M, a decrease of -97.77%. That is a compound annual growth rate of -18.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 7.39M | -9.59% |
| Dec 30, 2025 | 8.17M | 31.74% |
| Dec 30, 2024 | 6.20M | -15.53% |
| Dec 29, 2023 | 7.34M | -34.64% |
| Dec 30, 2022 | 11.23M | -73.95% |
| Dec 30, 2021 | 43.12M | -28.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 8.06M |
| Processa Pharmaceuticals | 7.93M |
| TransCode Therapeutics | 7.81M |
| PharmaCyte Biotech | 7.75M |
| GridAI Technologies | 7.63M |
| Indaptus Therapeutics | 7.40M |
| Aptorum Group | 7.31M |
| Acurx Pharmaceuticals | 7.27M |